JP Morgan Initiates Coverage On Dianthus Therapeutics with Overweight Rating, Announces Price Target of $135

Benzinga Newsdesk www.benzinga.com Neutral 51.1%

Neg 0% Neu 51.1% Pos 0%

JP Morgan analyst Brian Cheng initiates coverage on Dianthus Therapeutics (NASDAQ:DNTH) with a Overweight rating and announces Price Target of $135.